Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis.

Kloprogge, Frank; Mwandumba, Henry C; Banda, Gertrude; Kamdolozi, Mercy; Shani, Doris; Corbett, Elizabeth L; Kontogianni, Nadia; Ward, Steve; Khoo, Saye H; Davies, Geraint R; +1 more... Sloan, Derek J; (2020) Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis. OPEN FORUM INFECTIOUS DISEASES, 7 (7). ofaa218-. ISSN 2328-8957 DOI: https://doi.org/10.1093/ofid/ofaa218

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/ofid/ofaa218

Abstract

Item Type Article
Faculty and Department Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
Research Centre TB Centre
PubMed ID 32733976
Elements ID 149734

Share

Download

Filename: Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tubercu.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar